Fujiwara T
Department of Pediatrics, Iwate Medical University, Morioka.
Nihon Sanka Fujinka Gakkai Zasshi. 1988 Aug;40(8):1033-43.
RDS is the major cause of morbidity and mortality in preterm infants. Hochheim first noted the pathologic appearance of the lungs with RDS in 1903, which included alveolar collapse associated with dilatation of the alveolar ducts and terminal bronchioles. This important finding now can be best explained by the newer model of pulmonary micromechanics proposed by Weibel and Bachofen. In this model, alveoli are not individual structures, but subunits of the alveolar duct system. The alveolar stability requires particular properties of both the fibrous skeleton and the alveolar surfactant film. With increasing surface forces resulting from surfactant deficiency, the alveolar volumes and surface areas decrease, more septal segments are folded up between the adjacent ducts, thereby widening the duct system and terminal bronchioles. In this situation, the shear forces triggered by mechanical ventilation cause damage of the terminal airways with increased permeability of plasma proteins into the airspaces, which tends to aggravate alveolar instability further. Exogenous surfactant replacement produced excellent results which decreased the pulmonary complications of RDS significantly with no adverse effects. In the not too distant future this therapy will be regularly practiced in NICU.
呼吸窘迫综合征(RDS)是早产儿发病和死亡的主要原因。1903年,霍希海姆首次指出了患有RDS的婴儿肺部的病理表现,其中包括与肺泡管和终末细支气管扩张相关的肺泡塌陷。现在,这一重要发现可以用韦贝尔和巴赫芬提出的肺微力学新模型得到最好的解释。在这个模型中,肺泡不是单个结构,而是肺泡管系统的亚单位。肺泡的稳定性需要纤维骨架和肺泡表面活性物质膜都具备特定的特性。由于表面活性物质缺乏导致表面力增加,肺泡体积和表面积减小,更多的间隔段在相邻管道之间折叠起来,从而使管道系统和终末细支气管变宽。在这种情况下,机械通气引发的剪切力会导致终末气道受损,血浆蛋白渗入气腔的通透性增加,这往往会进一步加重肺泡的不稳定性。外源性表面活性物质替代疗法取得了出色的效果,显著降低了RDS的肺部并发症,且无不良反应。在不久的将来,这种疗法将在新生儿重症监护病房(NICU)常规应用。